Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Continuous Glucose Monitoring (CGM) in Prediabetes With Community Based Recruitment

NCT: NCT07477249 · RECRUITING

NCT IDNCT07477249
StatusRECRUITING
Start Date2026-02-26
Completion2027-03-30

Brief Summary

The objective of this project is to develop a behavioral intervention that combines wearable continuous glucose monitoring (CGM) with smartphone feedback and educational video clips generated by artificial intelligence (AI) software to improve glycemic control among individuals with pre-diabetes. The goal is to prevent transition to type 2 diabetes (T2D).

Frequently Asked Questions

What is Continuous Glucose Monitoring (CGM) in Prediabetes With Community Based Recruitment?

Continuous Glucose Monitoring (CGM) in Prediabetes With Community Based Recruitment is a clinical trial registered under NCT07477249. Current status: RECRUITING.

What is the status of NCT07477249?

The current status of NCT07477249 (Continuous Glucose Monitoring (CGM) in Prediabetes With Community Based Recruitment) is: RECRUITING.

When did Continuous Glucose Monitoring (CGM) in Prediabetes With Community Based Recruitment start?

Continuous Glucose Monitoring (CGM) in Prediabetes With Community Based Recruitment started on 2026-02-26.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑